体能-话题@MedSci

#体能#

45篇内容 | 933人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1770525, encodeId=2f381e70525b9, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=新里程碑临床研究：后生元尿石素A (Mitopure™)可提高中年人肌肉力量和运动体能, objectType=article, longId=727373, objectId=54b0e2737391, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54b0e2737391, replyNumber=0, likeNumber=45, createdTime=2022-08-25, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54b0e2737391, moduleTitle=新里程碑临床研究：后生元尿石素A (Mitopure™)可提高中年人肌肉力量和运动体能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54b0e2737391)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1770524, encodeId=cb8a1e70524de, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=AJH：针对 B 细胞成熟抗原的 CAR-T 细胞疗法对复发/难治性多发性骨髓瘤有效，包括体能状态不佳的病例, objectType=article, longId=726769, objectId=f014e26769c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f014e26769c3, replyNumber=0, likeNumber=30, createdTime=2022-10-28, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f014e26769c3, moduleTitle=AJH：针对 B 细胞成熟抗原的 CAR-T 细胞疗法对复发/难治性多发性骨髓瘤有效，包括体能状态不佳的病例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f014e26769c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1770522, encodeId=76871e70522fc, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=2021年11月23日简报：中国研发的中和抗体能降低78%的住院和死亡率，有望年底上市；美前卫生局长警告称美新冠病例今冬或激增, objectType=article, longId=220871, objectId=aad32208e110, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aad32208e110, replyNumber=0, likeNumber=39, createdTime=2022-05-08, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aad32208e110, moduleTitle=2021年11月23日简报：中国研发的中和抗体能降低78%的住院和死亡率，有望年底上市；美前卫生局长警告称美新冠病例今冬或激增, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aad32208e110)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1770523, encodeId=1c591e70523a9, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=中和抗体能对抗奥密克戎（Omicron）突变株吗？谢晓亮教授给您答案（附下载）, objectType=article, longId=264984, objectId=153f264984af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=153f264984af, replyNumber=0, likeNumber=47, createdTime=2022-01-12, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=153f264984af, moduleTitle=中和抗体能对抗奥密克戎（Omicron）突变株吗？谢晓亮教授给您答案（附下载）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=153f264984af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1770521, encodeId=8f3a1e7052154, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=mRNA新冠疫苗，打第三针，中和抗体能达到什么水平？, objectType=article, longId=215016, objectId=74052150168b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74052150168b, replyNumber=0, likeNumber=29, createdTime=2022-04-25, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74052150168b, moduleTitle=mRNA新冠疫苗，打第三针，中和抗体能达到什么水平？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74052150168b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1770518, encodeId=a3cb1e7051847, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=Nat Commun：懒癌福利——不运动也健康，新运动激素能让老年体能翻倍！, objectType=article, longId=207321, objectId=b2a320e32123, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2a320e32123, replyNumber=0, likeNumber=38, createdTime=2021-09-25, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2a320e32123, moduleTitle=Nat Commun：懒癌福利——不运动也健康，新运动激素能让老年体能翻倍！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2a320e32123)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1770519, encodeId=2e8a1e705191e, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=Nat Commun：武汉地区的新冠康复者血清抗体能持续多久？, objectType=article, longId=214013, objectId=ab9d214013e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab9d214013e5, replyNumber=0, likeNumber=43, createdTime=2022-05-23, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab9d214013e5, moduleTitle=Nat Commun：武汉地区的新冠康复者血清抗体能持续多久？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab9d214013e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1770520, encodeId=19db1e70520fb, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=EClinicalMedicine：国药新冠疫苗接种第3剂，中和抗体能达到什么水平？, objectType=article, longId=214945, objectId=42612149451a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42612149451a, replyNumber=0, likeNumber=64, createdTime=2022-02-14, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42612149451a, moduleTitle=EClinicalMedicine：国药新冠疫苗接种第3剂，中和抗体能达到什么水平？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42612149451a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1770516, encodeId=d72e1e70516fe, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=PLoS Genet：编码限制性羧基末端结构域的SLC12A2变异体能够引起人类遗传性听力损失 , objectType=article, longId=193975, objectId=fd461939e548, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd461939e548, replyNumber=0, likeNumber=52, createdTime=2020-05-24, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd461939e548, moduleTitle=PLoS Genet：编码限制性羧基末端结构域的SLC12A2变异体能够引起人类遗传性听力损失 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd461939e548)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1770514, encodeId=f3021e7051415, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=Oncogene：毒蕈碱受体能够促进前列腺癌的去势抵抗性生长, objectType=article, longId=191891, objectId=de39191891d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de39191891d6, replyNumber=0, likeNumber=45, createdTime=2020-05-23, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de39191891d6, moduleTitle=Oncogene：毒蕈碱受体能够促进前列腺癌的去势抵抗性生长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de39191891d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1770517, encodeId=832a1e705177c, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=NAT COMMUN：神兽”的抗体果然神奇！研究发现，羊驼抗体能“绑定”在SARS-CoV-2上，有效阻止其感染宿主, objectType=article, longId=200489, objectId=482f2004893c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=482f2004893c, replyNumber=0, likeNumber=34, createdTime=2020-11-21, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=482f2004893c, moduleTitle=NAT COMMUN：神兽”的抗体果然神奇！研究发现，羊驼抗体能“绑定”在SARS-CoV-2上，有效阻止其感染宿主, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=482f2004893c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1770512, encodeId=356a1e705125f, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=Int J Pharm：CD13特异性配体能够促进苍儿素纳米药物靶向树突细胞来治疗难治性过敏性鼻炎, objectType=article, longId=187666, objectId=60c818e6662e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60c818e6662e, replyNumber=0, likeNumber=48, createdTime=2020-02-16, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60c818e6662e, moduleTitle=Int J Pharm：CD13特异性配体能够促进苍儿素纳米药物靶向树突细胞来治疗难治性过敏性鼻炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60c818e6662e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1770513, encodeId=879c1e7051363, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=Oncogene：具有短聚谷氨酸尾巴的雄激素受体能够增强Wnt/β-连环蛋白介导的前列腺致瘤过程, objectType=article, longId=189352, objectId=d033189352cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d033189352cf, replyNumber=0, likeNumber=34, createdTime=2021-01-19, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d033189352cf, moduleTitle=Oncogene：具有短聚谷氨酸尾巴的雄激素受体能够增强Wnt/β-连环蛋白介导的前列腺致瘤过程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d033189352cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1770510, encodeId=69851e7051086, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=Sci Signal：骨骼肌分泌BDNF控制机体能量代谢且存在性别差异, objectType=article, longId=178904, objectId=17b21e890426, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17b21e890426, replyNumber=0, likeNumber=50, createdTime=2019-09-08, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17b21e890426, moduleTitle=Sci Signal：骨骼肌分泌BDNF控制机体能量代谢且存在性别差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17b21e890426)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1770515, encodeId=c3571e7051511, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=JACC：体能是生命体征！尽管医疗进步，体能不足者仍死亡率较高 , objectType=article, longId=192714, objectId=f6e3192e1422, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6e3192e1422, replyNumber=0, likeNumber=43, createdTime=2020-06-19, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6e3192e1422, moduleTitle=JACC：体能是生命体征！尽管医疗进步，体能不足者仍死亡率较高 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6e3192e1422)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1770511, encodeId=8cd21e705112b, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=Oncogene：拮抗剂贝沙罗汀靶向TR4核受体能够增加前列腺癌对多烯紫杉醇的敏感性, objectType=article, longId=184301, objectId=1ec6184301de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ec6184301de, replyNumber=0, likeNumber=39, createdTime=2020-11-03, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ec6184301de, moduleTitle=Oncogene：拮抗剂贝沙罗汀靶向TR4核受体能够增加前列腺癌对多烯紫杉醇的敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ec6184301de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1770509, encodeId=ecd01e70509c3, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=Nature：补肾？如何重编程身体能量之路？, objectType=article, longId=155102, objectId=e4df155102d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4df155102d2, replyNumber=0, likeNumber=36, createdTime=2019-10-21, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4df155102d2, moduleTitle=Nature：补肾？如何重编程身体能量之路？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4df155102d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1770508, encodeId=a8ae1e7050815, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=Nature：迟洪波组报道免疫与线粒体能量代谢的连接纽带, objectType=article, longId=142072, objectId=ef711420e212, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef711420e212, replyNumber=0, likeNumber=34, createdTime=2018-12-18, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef711420e212, moduleTitle=Nature：迟洪波组报道免疫与线粒体能量代谢的连接纽带, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef711420e212)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1770506, encodeId=05b21e705061b, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=Brit J Cancer：前列腺素受体能够诱导泌尿道上皮致瘤作用和膀胱癌恶化以及顺铂抗性, objectType=article, longId=120739, objectId=0ad2120e3921, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ad2120e3921, replyNumber=0, likeNumber=38, createdTime=2018-01-14, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ad2120e3921, moduleTitle=Brit J Cancer：前列腺素受体能够诱导泌尿道上皮致瘤作用和膀胱癌恶化以及顺铂抗性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ad2120e3921)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1770507, encodeId=5ebe1e70507da, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, objectTitle=Biomater Sci：新的SS-31修饰脂质体能够改善二甲胺四环素对药物诱导听力损失的保护作用, objectType=article, longId=138689, objectId=83ac13868928, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83ac13868928, replyNumber=0, likeNumber=32, createdTime=2018-08-19, rootId=0, userName=liubm568, userId=80ae38174281, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83ac13868928, moduleTitle=Biomater Sci：新的SS-31修饰脂质体能够改善二甲胺四环素对药物诱导听力损失的保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83ac13868928)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

体能

2020-05-29

liubm568 (审核中...)

前往app查看评论内容

#体能#

新里程碑临床研究：后生元尿石素A (Mitopure™)可提高中年人肌肉力量和运动体能

2022-08-25

liubm568 (审核中...)

前往app查看评论内容

#体能#

AJH：针对 B 细胞成熟抗原的 CAR-T 细胞疗法对复发/难治性多发性骨髓瘤有效，包括体能状态不佳的病例

2022-10-28

liubm568 (审核中...)

前往app查看评论内容

#体能#

2021年11月23日简报：中国研发的中和抗体能降低78%的住院和死亡率，有望年底上市；美前卫生局长警告称美新冠病例今冬或激增

2022-05-08

liubm568 (审核中...)

前往app查看评论内容

#体能#

中和抗体能对抗奥密克戎（Omicron）突变株吗？谢晓亮教授给您答案（附下载）

2022-01-12

liubm568 (审核中...)

前往app查看评论内容

#体能#

mRNA新冠疫苗，打第三针，中和抗体能达到什么水平？

2022-04-25

liubm568 (审核中...)

前往app查看评论内容

#体能#

Nat Commun：懒癌福利——不运动也健康，新运动激素能让老年体能翻倍！

2021-09-25

liubm568 (审核中...)

前往app查看评论内容

#体能#

Nat Commun：武汉地区的新冠康复者血清抗体能持续多久？

2022-05-23

liubm568 (审核中...)

前往app查看评论内容

#体能#

EClinicalMedicine：国药新冠疫苗接种第3剂，中和抗体能达到什么水平？

2022-02-14

liubm568 (审核中...)

前往app查看评论内容

#体能#

PLoS Genet：编码限制性羧基末端结构域的SLC12A2变异体能够引起人类遗传性听力损失

2020-05-24

liubm568 (审核中...)

前往app查看评论内容

#体能#

Oncogene：毒蕈碱受体能够促进前列腺癌的去势抵抗性生长

2020-05-23

liubm568 (审核中...)

前往app查看评论内容

#体能#

NAT COMMUN：神兽”的抗体果然神奇！研究发现，羊驼抗体能“绑定”在SARS-CoV-2上，有效阻止其感染宿主

2020-11-21

liubm568 (审核中...)

前往app查看评论内容

#体能#

Int J Pharm：CD13特异性配体能够促进苍儿素纳米药物靶向树突细胞来治疗难治性过敏性鼻炎

2020-02-16

liubm568 (审核中...)

前往app查看评论内容

#体能#

Oncogene：具有短聚谷氨酸尾巴的雄激素受体能够增强Wnt/β-连环蛋白介导的前列腺致瘤过程

2021-01-19

liubm568 (审核中...)

前往app查看评论内容

#体能#

Sci Signal：骨骼肌分泌BDNF控制机体能量代谢且存在性别差异

2019-09-08

liubm568 (审核中...)

前往app查看评论内容

#体能#

JACC：体能是生命体征！尽管医疗进步，体能不足者仍死亡率较高

2020-06-19

liubm568 (审核中...)

前往app查看评论内容

#体能#

Oncogene：拮抗剂贝沙罗汀靶向TR4核受体能够增加前列腺癌对多烯紫杉醇的敏感性

2020-11-03

liubm568 (审核中...)

前往app查看评论内容

#体能#

Nature：补肾？如何重编程身体能量之路？

2019-10-21

liubm568 (审核中...)

前往app查看评论内容

#体能#

Nature：迟洪波组报道免疫与线粒体能量代谢的连接纽带

2018-12-18

liubm568 (审核中...)

前往app查看评论内容

#体能#

Brit J Cancer：前列腺素受体能够诱导泌尿道上皮致瘤作用和膀胱癌恶化以及顺铂抗性

2018-01-14

liubm568 (审核中...)

前往app查看评论内容

#体能#

Biomater Sci：新的SS-31修饰脂质体能够改善二甲胺四环素对药物诱导听力损失的保护作用

2018-08-19

科室
- - 订阅+
  - 更多科室
工具
服务